ThermoSafer XST600: 비침습 무선 심부 체온 모니터링 온도계

Background Problem:Core Body Temperatureis recognized as a very important indicator in intensive care management, but existing methods rely on invasive methods of inserting sensors into the esophagus or rectum, making it difficult to use in general wards or homes. With the increasing demand for continuous temperature monitoring for the care of the elderly and infants, and for infectious disease monitoring, there was a need for a safe and easy way to measure core body temperature.

Limitations of existing methods: Invasive catheter thermometers are burdensome to patients and are only used in limited environments such as intensive care units. Non-invasive infrared thermometers do not accurately reflect core temperature and cannot be measured continuously. As a result, the lack of real-time continuous monitoring makes it difficult to detect emergencies early and cannot be used for care outside of hospitals.

ThermoSafer XST600 is a world-class solution that continuously measures body temperature with a skin-attachable sensor without the need for internal insertion. It calculates accurate and stable core body temperature values with a self-developed heat flux modeling algorithm, and transmits them in real time to a mobile app or hospital monitor via BLE 5.0 communication.

The reusable main body + disposable probe structure maintains hygiene while reducing cost burden. In addition, it has a wide range of applications from hospital wards and operating rooms to monitoring infants and the elderly at home, remote chronic disease management, and large-scale screening at airports, realizing democratized temperature monitoring from medical care to public health.

A mix of hospitals and nursing facilities (B2B) and patients/caregivers at home (B2C). Initially, medical institutions will introduce it for monitoring post-operative patients or intensive care patients, and in the long term, families of patients with chronic diseases or nursing facilities can purchase it as a home medical device. Public institutions such as airports and stations are also likely to adopt it in large quantities.

Technically, it can be used without national or environmental restrictions, and has already received attention at global exhibitions in the United States and the Middle East. However, medical device approvals are required in each region, and clinical reliability must be sufficiently proven.

Choicem科技有限公司 has already accumulated years of clinical experience and patents in Korea, and is seeking to expand partnerships and distribution networks through overseas exhibitions such as MEDICA in Germany and WHX in Dubai after CES. There is also room to expand this technology to wearable integration such as smart watches or other vital sign monitoring.

Selected as a winner in the "Human Security for All (HSFA)" special category at CES, it was highly evaluated as a technology that contributes to human health and safety. The level of technical completeness is at the level of medical device Class 2 certification aimed at clinical application, and accuracy verification has been conducted with clinical development experience with Seoul National University Hospital, etc.

Market expectations are high due to the increase in demand for hospitals and home care, but initial adoption depends on changes in the medical community's perception, as new medical habits need to be formed. Market verification has been insufficient to date (pre-market stage), but the CES award has raised global awareness and investment interest, further increasing the possibility of commercialization.